Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition

In 17 patients with primary mixed hyperlipidemia we studied levels and composition of lipoproteins in fasting plasma, lipoprotein-modifying enzymes, and postprandial lipoprotein metabolism after an oral fat-tolerance test supplemented with vitamin A before, and 12 weeks after treatment with etophyll...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Atherosclerosis 1995-10, Vol.117 (2), p.253-261
Hauptverfasser:	Föger, Bernhard, Tröbinger, Gabriele, Ritsch, Andreas, Lechleitner, Monika, Hopferwieser, Thomas, Menzel, Hans-Jürgen, Utermann, Gerd, Pfeiffer, Karl P., Patsch, Josef R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Carrier Proteins - blood Cholesterol Ester Transfer Proteins Cholesteryl ester transfer protein Chylomicron Chylomicrons - blood Clofibrate - analogs & derivatives Clofibrate - therapeutic use Eating Female Fibrate General and cellular metabolism. Vitamins Glycoproteins Hepatic lipase High density lipoprotein Humans Hyperlipidemias - blood Hyperlipidemias - drug therapy Hypolipidemic Agents - therapeutic use Lipase - blood Lipoprotein lipase Lipoprotein(a) - blood Lipoproteins - blood Male Medical sciences Middle Aged Pharmacology. Drug treatments Postprandial lipemia Transaminases - blood Triglycerides - blood Vitamin A - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!